It’s safe. It’s powerful.
It’s a No Brainer.
-
Peptylin®
-
NeurXcel™
-
Wild Canadian Blueberry
No other supplement in the world features our proprietary blend of ingredients found in nature.
Safe Ingredients. Radical Results.
-
Peptylin®
Pure silk protein peptides from silk moth cocoon fibers. Improves memory, focus, and executive function.* -
NeurXcel™
The richest-available plant-based omega-3-6-9 from a certified non-GMO source. Supports a healthy mood, fluid intelligence, brain integrity, and anti-inflammatory response post exercise.* -
Wild Canadian Blueberry
Increases natural antioxidant activity.*
The Science Behind Braini
Clinical Trials
-
Clinical Trial 1
-
Location
University of North Carolina Asheville -
Participants
31, 18-30 year olds -
Method
Double blind, placebo-controlled, randomized—the “gold standard” in studies, using CNS Vital Signs neurocognitive testing platform -
Results
The Braini formulation was found to improve executive function scores with statistical significance achieved (p=.02). On average there was a 7.8% increase in Executive Function scores after thirty days of taking two Braini capsules a day.
Also, the researchers found that subjects taking Braini experienced significantly improved CNS correct response shifting attention reaction time (SAT-RT) vs placebo by an average 1/10th of a second (p=.007). Researchers consider a p-value of less than .05 to be significant.
Executive Function measures “how well a subject recognizes rules, categories, and manages or navigates rapid decision making.” It relates to one’s “ability to sequence tasks and manage multiple tasks simultaneously as well as tracking and responding to a set of instructions.”
-
-
Clinical Trial 2
-
Location
University of North Carolina Asheville -
Participants
30, 50-80 year olds -
Method
Double blind, placebo-controlled, randomized—the “gold standard” in studies, using CNS Vital Signs neurocognitive testing platform -
Results
The Braini Formulation was found to increase CNS correct response shifting attention reaction time (SAT-RT) vs placebo with a p-value of .05 achieved, considered an indicative outcome meriting further study. The SAT-RT measure is a key component of the CNS Executive Function outcome score.
This finding means that the slower a subject’s baseline reaction time was before starting to take Braini, the better his or her reaction times were after 28 days, compared to subjects taking placebo.
Executive Function measures “how well a subject recognizes rules, categories, and manages or navigates rapid decision making.” It relates to one’s “ability to sequence tasks and manage multiple tasks simultaneously as well as tracking and responding to a set of instructions.”
-
-
Clinical Trial 3
-
Status
Currently underway at University of North Carolina Asheville
-
-
Mark Shapiro, PhD, Pharma Initiatives
Provides statistical research and analysis services to Braini for our clinical trials.
-
Mark Shapiro, PhD, Pharma Initiatives
Provides statistical research and analysis services to Braini for our clinical trials.
-
Mark Shapiro, PhD, Pharma Initiatives
Provides statistical research and analysis services to Braini for our clinical trials.